Sana Biotechnology Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

NasdaqGS:SANA Recent Insider Transactions by Companies or Individuals
Date	Value	Name	Entity	Role	Shares	Max Price
08 Mar 24	SellUS$236,300	Yuhmin Yang	Individual		25,000	US$9.45
08 Feb 24	BuyUS$9,999,996	Arch Venture Partners, L.P.	Company		1,818,181	US$5.50

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of SANA?
Owner Type	Number of Shares	Ownership Percentage
General Public	1,920,551	0.86%
Individual Insiders	21,491,566	9.63%
VC/PE Firms	70,862,537	31.7%
Institutions	128,994,235	57.8%

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 13.3%.

Top Shareholders

Top 25 shareholders own 90.63% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
20.5%	Arch Venture Partners, L.P.	45,860,681	US$80.3m	0%	7.59%
12%	FMR LLC	26,776,152	US$46.9m	19.9%	no data
11.2%	Flagship Pioneering, Inc	25,001,856	US$43.8m	0%	12.06%
5.9%	The Vanguard Group, Inc.	13,183,552	US$23.1m	2.37%	no data
5.29%	BlackRock, Inc.	11,817,295	US$20.7m	6.99%	no data
4.6%	Baillie Gifford & Co.	10,278,084	US$18.0m	-2.77%	0.01%
4.56%	Canada Pension Plan Investment Board	10,175,000	US$17.8m	0%	0.01%
3.97%	Steven Harr	8,856,250	US$15.5m	0%	no data
2.97%	State Street Global Advisors, Inc.	6,627,320	US$11.6m	4.24%	no data
2.63%	Capital Research and Management Company	5,879,035	US$10.3m	-0.04%	no data
2.59%	Hans Edgar Bishop	5,790,489	US$10.1m	0.1%	no data
2.16%	Impresa Management LLC	4,832,423	US$8.5m	0%	4.41%
1.46%	T. Rowe Price Group, Inc.	3,263,288	US$5.7m	-30.2%	no data
1.42%	Geode Capital Management, LLC	3,166,480	US$5.5m	9.55%	no data
1.38%	Crestline Investors Inc.	3,085,624	US$5.4m	-4.34%	0.29%
1.26%	GV Management Company, LLC	2,812,500	US$4.9m	0%	0.32%
1.21%	Richard Mulligan	2,698,121	US$4.7m	-10%	no data
1.07%	Baker Bros. Advisors LP	2,380,949	US$4.2m	0%	0.04%
0.81%	Integral Health Asset Management, LLC	1,800,000	US$3.1m	50%	0.39%
0.77%	Morgan Stanley, Investment Banking and Brokerage Investments	1,716,467	US$3.0m	20.2%	no data
0.69%	Sunil Agarwal	1,550,000	US$2.7m	0%	no data
0.69%	Tavistock Life Sciences	1,545,000	US$2.7m	0%	0.17%
0.51%	Northern Trust Global Investments	1,128,342	US$2.0m	32%	no data
0.48%	Dimensional Fund Advisors LP	1,078,900	US$1.9m	106%	no data
0.47%	Charles Schwab Investment Management, Inc.	1,047,846	US$1.8m	11.2%	no data

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2024/12/24 17:33
End of Day Share Price	2024/12/24 00:00
Earnings	2024/09/30
Annual Earnings	2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Sana Biotechnology, Inc. is covered by 12 analysts. 4 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Analyst	Institution
Geoffrey Meacham	BofA Global Research
Alec Stranahan	BofA Global Research
Samantha Lynn Semenkow	Citigroup Inc